Alexandra I. Russell

Antitrust Litigation

• In re Lipitor Antitrust Litigation (D.N.J.): Representing Sun Pharma and its Ranbaxy affiliates in a multidistrict putative class action litigation arising out of a patent litigation settlement concerning the cholesterol drug Lipitor®. Defeated direct and end-payor class certification motions and summary judgment granted in client’s favor on all claims. Alex argued the winning opposition to the direct-purchaser plaintiffs’ class certification motion and was recognized by The American Lawyer as a Litigator of the Week “runner up” for this “knockout win” for Sun.
• Value Drug v. Takeda Pharmaceuticals U.S.A. Inc., et al. (E.D. Pa.): Trial counsel for Teva and Amneal Pharmaceuticals in litigation alleging anticompetitive horizontal conspiracy concerning the gout drug Colcrys®. Defeated class certification twice.
• In re Ranbaxy Generic Drug Application Antitrust Litigation (D. Mass.): Representing Sun Pharma and its Ranbaxy affiliates in a multidistrict class action litigation alleging Ranbaxy obstructed competition by making fraudulent misrepresentations to the FDA in seeking approval for its generic versions of blockbuster drugs, Nexium®, Valcyte® and Diovan®.
• In re Effexor XR Antitrust Litigation (D.N.J.): Representing Teva in a multidistrict putative class action litigation arising out of a patent litigation settlement concerning the antidepressant drug Effexor®. In 2018, the court granted in part Teva’s motion for judgment on the pleadings. Ongoing as to the remaining claims.
• In re Niaspan Antitrust Litigation (E.D. Pa., CA3): Representing Teva in a multi-district class action litigation arising out of a patent litigation settlement concerning the cholesterol drug Niaspan®. Defeated end-payor class certification twice. Ruling was affirmed on appeal in a precedential Third Circuit decision.

Restructuring Litigation

• HONX, Inc. (Bkr. S.D. Tex.): Representing HONX, Inc. (a wholly-owned subsidiary of Hess Corporation) in its successful 524(g) Chapter 11 case that resolved hundreds of personal injury lawsuits stemming from alleged exposure to asbestos at an oil refinery in St. Croix.
• Chesapeake Energy (Bkr. S.D. Tex.): Trial counsel for Chesapeake Energy Corporation and 40 of its subsidiaries in their high-profile Chapter 11 cases and related litigation proceedings. In 2021, after a three-week trial against the official committee of unsecured creditors concerning confirmation and valuation issues, the court confirmed Chesapeake’s plan of reorganization.
• Gulfport Energy (Bkr. S.D. Tex.): Trial counsel for Gulfport Energy and its subsidiaries in their Chapter 11 cases and related litigation proceedings. The American Lawyer recognized Alex as a Litigator of the Week “runner up” for her work on this matter.
• Magnum Hunter (Bkr. D. Del.): Represented Magnum Hunter Resources Corporation and its subsidiaries in their Chapter 11 cases in the United States Bankruptcy Court for the District of Delaware.

Commercial Litigation

• Antero Resources (various matters): Representing Antero in various putative class actions in West Virginia brought by royalty owners claiming breach of oil and gas leases.
• Gulfport Energy (various matters): Representing Gulfport in lawsuits in Ohio and Oklahoma brought by royalty owners claiming breach of oil and gas leases.  
• GE v. Siemens Energy, Inc. (E.D. Va.); Mitsubishi v. Siemens Energy, Inc. (M.D. Fla.): Represented Siemens Energy, Inc. in cases brought by competitors alleging trade secrets misappropriation in the gas turbine industry.
• Chesapeake Energy (various matters): Representing Chesapeake Energy and affiliates in certified Ohio class actions claiming breach of natural gas leases. Summary judgment entered in client’s favor in each case. Henceroth v. Chesapeake Exploration, L.L.C., 2019 WL 4750661 (N.D. Ohio, Sept. 30, 2019), affirmed 814 Fed. Appx. 67 (6th Cir., 2020) and Zehentbauer v. Chesapeake Exploration, L.L.C., 450 F. Supp. 3d 790 (N.D. Ohio, 2020).